Risk for Heart Failure Modulate the Effectiveness of Empagliflozin ?

 

This interview with Javed Butler from Stony Brook University, New York, USA discusses Does the Risk for Heart Failure Modulate the Effectiveness of Empagliflozin on Heart Failure Hospitalization or Cardiovascular Death in Patients with Type 2 Diabetes without Heart Failure? at ESC 2017.